Research funder · Australia
Therapeutic Innovation Australia
- Grants since 2016
- 310
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 146
- Funded works, all time
- 282
Grants
2026
Screening for therapeutic antibodies to treat chronic pain
2026
Development of a selective inhibitor of metastatic relapse
2026
Microbiome derived IBD small molecule
2026
Therapeutics for NAXD disorder – a newly described fatal encephalopathy triggered by fever
2026
A stem cell powered drug discovery pipeline for non-tuberculous mycobacteria
2026
Development of advanced and novel radioligands for Positron Emission Tomography (PET) imaging
2026
Development of Small Molecules to Promote Remyelination in Multiple Sclerosis
2026
Exploring the Feasibility of Tumour Infiltrating Lymphocyte (TIL) Therapy in Appendiceal Cancer
2026
Development of a vaccine to prevent Group A Streptococcus pharyngeal infection
2026
High-Throughput 3D Cell and Organism Screening for new brain cancer (glioma) treatments
2026
Discovery of new therapies for hypertrophic cardiomyopathy in Noonan syndrome using a hiPSC-based high-throughput drug screening platform
2026
Evaluating technical feasibility of cGMP production of bioengineered heart tissue to treat heart failure in congenital heart disease
2026
Development of a high-throughput drug screening platform for paediatric brain tumours using advanced cancer-brain organoid models
2026
Design, Scale-up and Manufacturability of a Safe and Effective TcdB Immunogen to Support the Development of an Oral Therapy for the Treatment of Clostridioides difficile infections.
2026
Development of an mRNA cytotoxic T-cell COVID-19 vaccine
2026
Using fragment-based drug discovery to identify small molecule inhibitors of SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase (RdRp) and future starting points for other Coronaviruses
2026
Pharmacokinetic Assessments and optimisation of a new therapy for PKD
2026
Development of a small molecule inhibitor of the MYB oncogene as a therapeutic for Acute Myeloid Leukaemia
2026
A new treatment for the cystic fibrosis superbug, Mycobacteroides abscessus
2026
In Vivo mRNA CAR T Cell Engineering via Targeted Lipid Nanoparticles
2026
Novel disease-modifying approach to treat pulmonary hypertension
2026
Pharmacokinetic profiling of two novel antiviral coronavirus protease inhibitors towards clinical application for COVID-19 and beyond.
2026
The establishment of a repository of in vitro-expanded T cells for the treatment of viral complications in transplant recipients
2026
In-vivo generation of chimeric antigen receptor (CAR) T-cells using lipid nanoparticles to treat autoimmune kidney disease
2026
Optimisation and Characterisation of Miltuximab-DFO Bioconjugation
2026
mRNA LNP vaccine design for endemic and emerging Henipaviral diseases.
2026
Identify drugs that selectively inhibit oestrogen receptor positive luminal progenitor activity
2026
Validation of GMP-compliant manufacture of corneal endothelial cells for intraocular injection as an alternative to corneal transplantation
2026
Novel brain peptide receptor analgesics: Accelerated target validation and pre-clinical testing of RXFP3 activators
2026
Screening and validation of novel therapeutic agents for inflammation resolution and neuroprotection in Parkinson's disease
2026
Development of NAMPT-cif Fc fusion for treatment of muscle disease
2026
Broad-spectrum Japanese Encephalitis virus vaccines using ancestral state reconstruction
2026
Discovery of novel therapeutic compounds targeting the microbiome-immune axis in ulcerative colitis
2026
Improving the accessibility of adeno-associated virus (AAV) gene therapy
2026
Development of a chlamydial vaccine for koalas: Production of chlamydial proteins at high quality suitable for vaccine trials
2026
Target Identification for Small molecule Therapeutics in Asthma
2026
Development of a platform for the automated generation and high-throughput drug screening of brain organoids
2026
Inhibiting cyst formation in polycystic kidney disease with targeted protein degraders (TPDs)
2026
Biodegradable Microcarriers for Therapeutic Stem Cells: A Feasibility Analysis for Large-Scale Production
2026